Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells

  • Authors:
    • Shiyong Wang
    • Xue Zeng
    • Yanping Liu
    • Chunyan Liang
    • Hui Zhang
    • Chang Liu
    • Weili Du
    • Zhe Zhang
  • View Affiliations

  • Published online on: April 3, 2012     https://doi.org/10.3892/or.2012.1756
  • Pages: 91-98
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The function and mechanism of the programmed cell death 5 (PDCD5) gene is not completely understood, so it is necessary to build a stable and efficient PDCD5 recombinant lentiviral expression vector. The coding region of the PDCD5 gene was PCR amplified from pCMV-SPORT6. Next, the PDCD5 fragment and the pGC-FU vector were digested with the restriction enzyme AgeI and ligated by in-Fusion technology to build the pGC-FU-PDCD5 plasmid. Competent E. coli DH5α cells were transformed and positive clones were identified by PCR. The PCR products were digested and sequenced. After sequencing, positive clones were selected to grow and propagate. The pGC-FU-PDCD5 plasmid DNA was purified and mixed with the pHelper1.0 and pHelper2.0 packaging plasmids. They were co-transfected into 293T cells. The viral titer was measured by real-time PCR. The expression of GFP and PDCD5 was detected by both Western blotting and fluorescence microscopy. Additionally, the A498, ACHN, HCT116 and LoVo tumor cell lines were transfected with the virus supernatant, and PDCD5 expression was detected in these cells. The constructed pGC-FU-PDCD5 plasmid contained the correct PDCD5 gene sequence. Strong green fluorescence in both the cytoplasm and cell membrane was observed following transfection with purified pGC-FU-PDCD5 into 293T cells. The transfection rate was greater than 95%, and the expression of the PDCD5-GFP fusion protein was confirmed by Western blotting. The titer of the recombinant PDCD5 lentiviral condensed supernatant was measured to be 2x109 Tu/ml. The transfection efficiencies of A498, ACHN and HCT116 cells were greater than 90%. However, transfection efficiency of LoVo cells was lower but still greater than 70%. The PDCD5-GFP fusion protein was stable in these transfected tumor cells, as detected by Western blotting. In conclusion, a PDCD5 recombinant lentiviral vector was successfully constructed, and high expression of the plasmid was observed in tumor cells.

Related Articles

Journal Cover

July 2012
Volume 28 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Zeng X, Liu Y, Liang C, Zhang H, Liu C, Du W and Zhang Z: Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells. Oncol Rep 28: 91-98, 2012
APA
Wang, S., Zeng, X., Liu, Y., Liang, C., Zhang, H., Liu, C. ... Zhang, Z. (2012). Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells. Oncology Reports, 28, 91-98. https://doi.org/10.3892/or.2012.1756
MLA
Wang, S., Zeng, X., Liu, Y., Liang, C., Zhang, H., Liu, C., Du, W., Zhang, Z."Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells". Oncology Reports 28.1 (2012): 91-98.
Chicago
Wang, S., Zeng, X., Liu, Y., Liang, C., Zhang, H., Liu, C., Du, W., Zhang, Z."Construction and characterization of a PDCD5 recombinant lentivirus vector and its expression in tumor cells". Oncology Reports 28, no. 1 (2012): 91-98. https://doi.org/10.3892/or.2012.1756